| Accord Healthcare AG - Temozolomid Accord 250 mg, Kapseln | | 67020 | | 06 | | Temozolomid Accord 250 mg | | Kapseln | | L01AX03 | | Temozolomid | | 02.12.2019 | | |
| | Composition | | temozolomidum 250 mg, lactosum 182.5 mg, silica colloidalis anhydrica, carboxymethylamylum natricum A corresp. natrium 1.68 mg, acidum tartaricum, acidum stearicum, Kapselhülle: gelatina, aqua, E 171, Drucktinte: lacca, kalii hydroxidum, E 172 (nigrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Temozolomide | 250 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Temozolomide | 250 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| | | | | | | | | Acide Tartarique | | | | Aqua | | | | | | | | | | color. | | | | color. | | Gelatina | | Kapselhülle | | | | | | | | Drucktinte | | | 182.5 mg | | | | | | | Silica Colloidalis Anhydrica | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 021 | 5 | 445.02 | 500.40 | A | LS | Non |
|
|
